Lyophilized from 0.22 µm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Expression System:
HEK293
Purity:
> 95% as determined by Bis-Tris PAGE,> 95% as determined by HPLC
Form:
Lyophilized
Sequence:
Met1-Ala54 (R27P)
Target:
BCMA/TNFRSF17
Immobilized Human BCMA (R27P), His Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human APRIL (Trimer), His Avi Tag with the EC50 of 33.8ng/ml determined by ELISA.
The purity of Human BCMA (R27P) is greater than 95% as determined by SEC-HPLC.
Human BCMA (R27P) on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Immobilized Human BCMA (R27P), His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human BAFF, hFc Tag with the EC50 of 3.8ng/ml determined by ELISA.
Immobilized Human BCMA (R27P), His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-BCMA Antibody, hFc Tag with the EC50 of 9.1ng/ml determined by ELISA.
* VAT and and shipping costs not included. Errors and price changes excepted
